-
公开(公告)号:US20220267775A1
公开(公告)日:2022-08-25
申请号:US17571251
申请日:2022-01-07
IPC分类号: C12N15/113 , A61K45/06 , A61K47/02 , A61K47/54 , A61K47/64
摘要: Pharmaceutical formulations for the treatment of cancer comprising novel siRNAs that downregulate expression of the PRDM oncoprotein gene and inhibit tumor growth. siRNAs designed and selected to destroy PRDM14 mRNA are described. The siRNAs are delivered via one or more targeted drug delivery systems equipped with a tumor-specific targeting ligand that confers specific binding of the nanoparticle with siRNA payload to receptors on the surface of tumor cells.